A-share traditional Chinese medicine (TCM) stocks saw a short-term surge, with Hansen Pharmaceutical hitting the daily limit, Zhenbaodao rising over 7%, and other stocks such as Yisheng Pharmaceutical, Enwei Pharmaceutical, Xinguang Pharmaceutical, and Teyi Pharmaceutical following suit. This surge was driven by news of the release of the "15th Five-Year Plan for the Revitalization and Development of Traditional Chinese Medicine."